109 related articles for article (PubMed ID: 17998065)
1. Hypoxia-inducible factor 1 inhibitors.
Melillo G
Methods Enzymol; 2007; 435():385-402. PubMed ID: 17998065
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting hypoxia-inducible factor 1 for cancer therapy.
Melillo G
Mol Cancer Res; 2006 Sep; 4(9):601-5. PubMed ID: 16940159
[TBL] [Abstract][Full Text] [Related]
3. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
4. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
5. Targeting hypoxia cell signaling for cancer therapy.
Melillo G
Cancer Metastasis Rev; 2007 Jun; 26(2):341-52. PubMed ID: 17415529
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
7. [Recent progress in the study on antitumor drugs targeting hypoxia-inducible factor-1].
Wang JJ; Li J; Geng MY
Yao Xue Xue Bao; 2008 Jun; 43(6):565-9. PubMed ID: 18822956
[TBL] [Abstract][Full Text] [Related]
8. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of HIF-1 inhibitors as anticancer agents.
Semenza GL
Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
[TBL] [Abstract][Full Text] [Related]
10. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
Poon E; Harris AL; Ashcroft M
Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
[TBL] [Abstract][Full Text] [Related]
11. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of hypoxia inducible factor in renal cell carcinoma.
Smaldone MC; Maranchie JK
Urol Oncol; 2009; 27(3):238-45. PubMed ID: 19414111
[TBL] [Abstract][Full Text] [Related]
14. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells.
Jung SN; Yang WK; Kim J; Kim HS; Kim EJ; Yun H; Park H; Kim SS; Choe W; Kang I; Ha J
Carcinogenesis; 2008 Apr; 29(4):713-21. PubMed ID: 18258605
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.
Elser M; Borsig L; Hassa PO; Erener S; Messner S; Valovka T; Keller S; Gassmann M; Hottiger MO
Mol Cancer Res; 2008 Feb; 6(2):282-90. PubMed ID: 18314489
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
18. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison.
Görlach A; Bonello S
Biochem J; 2008 Jun; 412(3):e17-9. PubMed ID: 18498249
[TBL] [Abstract][Full Text] [Related]
19. Baicalein induces functional hypoxia-inducible factor-1alpha and angiogenesis.
Cho H; Lee HY; Ahn DR; Kim SY; Kim S; Lee KB; Lee YM; Park H; Yang EG
Mol Pharmacol; 2008 Jul; 74(1):70-81. PubMed ID: 18426858
[TBL] [Abstract][Full Text] [Related]
20. Development of HIF-1 inhibitors for cancer therapy.
Onnis B; Rapisarda A; Melillo G
J Cell Mol Med; 2009 Sep; 13(9A):2780-6. PubMed ID: 19674190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
